As a consequence, the ACE2-Mb TM would not only function as a virus-neutralizing and anti-inflammatory drug but also redirect UniCAR T-cells originally administered to the patient as a cancer treatment to now also eliminate virus-infected cells. This evidence concerns the gene ACE2 and cancer.